Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients
Author(s) -
John A. Lednicky,
Michael Lauzardo,
Z. Hugh Fan,
Antarpreet Jutla,
Trevor B. Tilly,
Mayank Gangwar,
Moiz Usmani,
Sripriya Nannu Shankar,
Karim Mohamed,
Arantza Eiguren-Fernández,
Caroline J. Stephenson,
Md. Mahbubul Alam,
Maha A. Elbadry,
Julia C. Loeb,
Kuttichantran Subramaniam,
Thomas B. Waltzek,
Kartikeya Cherabuddi,
J. Glenn Morris,
ChangYu Wu
Publication year - 2020
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2020.09.025
Subject(s) - covid-19 , coronavirus , virology , virus , aerosol , sars virus , transmission (telecommunications) , airborne transmission , severe acute respiratory syndrome coronavirus , pandemic , medicine , infectious disease (medical specialty) , chemistry , disease , outbreak , pathology , organic chemistry , electrical engineering , engineering
Because the detection of SARS-CoV-2 RNA in aerosols but failure to isolate viable (infectious) virus are commonly reported, there is substantial controversy whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be transmitted through aerosols. This conundrum occurs because common air samplers can inactivate virions through their harsh collection processes. We sought to resolve the question whether viable SARS-CoV-2 can occur in aerosols using VIVAS air samplers that operate on a gentle water vapor condensation principle.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom